TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/4/24 21:40 | 12/2/24 | SPRY | Ars Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | M.dm | 15 | 1.50 | 0 | 10 | 6 | D | |||||||||||||||
12/4/24 21:40 | 12/2/24 | SPRY | Ars Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | S.dm | -140 | 14.04 | 0 | -10 | -64 | 6 | D | ||||||||||||||
9/19/24 16:30 | 9/18/24 | SPRY | Ars Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | M.d | 15 | 1.50 | 0 | 10 | 6 | D | |||||||||||||||
9/19/24 16:30 | 9/18/24 | SPRY | Ars Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | S.d | -140 | 14.00 | 0 | -10 | -64 | 6 | D | ||||||||||||||
8/21/24 18:51 | 8/19/24 | SPRY | Ars Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | M.d | 15 | 1.50 | 0 | 10 | 6 | D | |||||||||||||||
8/21/24 18:51 | 8/19/24 | SPRY | Ars Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | S.d | -140 | 14.00 | 0 | -10 | -64 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |